Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UspA2 is a major outer membrane protein of Moraxella catarrhalis that contributes to serum resistance by binding to C4BP, thereby inhibiting the complement cascade. It also functions as an adhesin, binding to extracellular matrix proteins and facilitating bacterial attachment to host cells. Genetic variations and recombination events can lead to altered binding properties and enhanced immune evasion. UspA2 is a promising vaccine candidate due to its high expression and immunogenicity.
N/A (Targeted by bactericidal antibodies; potential vaccine target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Moraxella catarrhalis ubiquitous surface protein A2 (UspA2).